Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Glutamatergic model psychoses: prediction error, learning, and inference.

Corlett PR, Honey GD, Krystal JH, Fletcher PC.

Neuropsychopharmacology. 2011 Jan;36(1):294-315. doi: 10.1038/npp.2010.163. Epub 2010 Sep 22. Review.

2.

From drugs to deprivation: a Bayesian framework for understanding models of psychosis.

Corlett PR, Frith CD, Fletcher PC.

Psychopharmacology (Berl). 2009 Nov;206(4):515-30. doi: 10.1007/s00213-009-1561-0. Epub 2009 May 28. Review.

3.
4.

Models of schizophrenia in humans and animals based on inhibition of NMDA receptors.

Bubeníková-Valesová V, Horácek J, Vrajová M, Höschl C.

Neurosci Biobehav Rev. 2008 Jul;32(5):1014-23. doi: 10.1016/j.neubiorev.2008.03.012. Epub 2008 Apr 8. Review.

PMID:
18471877
5.

Long-lasting changes in hippocampal synaptic plasticity and cognition in an animal model of NMDA receptor dysfunction in psychosis.

Wiescholleck V, Manahan-Vaughan D.

Neuropharmacology. 2013 Nov;74:48-58. doi: 10.1016/j.neuropharm.2013.01.001. Epub 2013 Jan 31. Review.

PMID:
23376021
6.

Frontal responses during learning predict vulnerability to the psychotogenic effects of ketamine: linking cognition, brain activity, and psychosis.

Corlett PR, Honey GD, Aitken MR, Dickinson A, Shanks DR, Absalom AR, Lee M, Pomarol-Clotet E, Murray GK, McKenna PJ, Robbins TW, Bullmore ET, Fletcher PC.

Arch Gen Psychiatry. 2006 Jun;63(6):611-21.

PMID:
16754834
7.

From prediction error to psychosis: ketamine as a pharmacological model of delusions.

Corlett PR, Honey GD, Fletcher PC.

J Psychopharmacol. 2007 May;21(3):238-52. Review.

PMID:
17591652
8.
9.

Individual differences in psychotic effects of ketamine are predicted by brain function measured under placebo.

Honey GD, Corlett PR, Absalom AR, Lee M, Pomarol-Clotet E, Murray GK, McKenna PJ, Bullmore ET, Menon DK, Fletcher PC.

J Neurosci. 2008 Jun 18;28(25):6295-303. doi: 10.1523/JNEUROSCI.0910-08.2008.

10.

Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study.

Deakin JF, Lees J, McKie S, Hallak JE, Williams SR, Dursun SM.

Arch Gen Psychiatry. 2008 Feb;65(2):154-64. doi: 10.1001/archgenpsychiatry.2007.37.

PMID:
18250253
12.

Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function.

Krystal JH, Perry EB Jr, Gueorguieva R, Belger A, Madonick SH, Abi-Dargham A, Cooper TB, Macdougall L, Abi-Saab W, D'Souza DC.

Arch Gen Psychiatry. 2005 Sep;62(9):985-94.

PMID:
16143730
13.

Impaired facial emotion recognition in a ketamine model of psychosis.

Ebert A, Haussleiter IS, Juckel G, Brüne M, Roser P.

Psychiatry Res. 2012 Dec 30;200(2-3):724-7. doi: 10.1016/j.psychres.2012.06.034. Epub 2012 Jul 7.

PMID:
22776754
14.

NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Krystal JH, D'Souza DC, Mathalon D, Perry E, Belger A, Hoffman R.

Psychopharmacology (Berl). 2003 Sep;169(3-4):215-33. Epub 2003 Sep 2. Review.

PMID:
12955285
15.

A review of NMDA receptors and the phencyclidine model of schizophrenia.

Thornberg SA, Saklad SR.

Pharmacotherapy. 1996 Jan-Feb;16(1):82-93. Review.

PMID:
8700797
16.

Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.

Vollenweider FX, Vontobel P, Oye I, Hell D, Leenders KL.

J Psychiatr Res. 2000 Jan-Feb;34(1):35-43.

PMID:
10696831
17.

Learning insights transmitted by glutamate.

Antzoulatos EG, Byrne JH.

Trends Neurosci. 2004 Sep;27(9):555-60. Review.

PMID:
15331238
18.

The NMDAr antagonist ketamine interferes with manipulation of information for transitive inference reasoning in non-human primates.

Brunamonti E, Mione V, Di Bello F, De Luna P, Genovesio A, Ferraina S.

J Psychopharmacol. 2014 Sep;28(9):881-7. doi: 10.1177/0269881114538543. Epub 2014 Jun 18.

PMID:
24944084
19.
20.

Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis.

de Bartolomeis A, Sarappa C, Buonaguro EF, Marmo F, Eramo A, Tomasetti C, Iasevoli F.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Oct 1;46:1-12. doi: 10.1016/j.pnpbp.2013.06.010. Epub 2013 Jun 23.

PMID:
23800465

Supplemental Content

Support Center